Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.

scientific article published on March 2014

Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/JAMAOPHTHALMOL.2013.6636
P698PubMed publication ID24385141
P5875ResearchGate publication ID262045776

P50authorEmily ChewQ24266614
Elvira AgrónQ83234331
Age-Related Eye Disease Study Research GroupQ83234373
Traci E ClemonsQ92993074
Frederick FerrisQ96025318
John Paul SanGiovanniQ114678175
Robert D SperdutoQ114678183
P2093author name stringMatthew D Davis
P433issue3
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
macular degenerationQ27429789
P304page(s)272-277
P577publication date2014-03-01
P1433published inJAMA OphthalmologyQ4787301
P1476titleTen-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
P478volume132

Reverse relations

cites work (P2860)
Q359184994-Acetoxyphenol Prevents RPE Oxidative Stress-Induced Necrosis by Functioning as an NRF2 Stabilizer
Q38898742A Revised Hemodynamic Theory of Age-Related Macular Degeneration
Q92214955A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration
Q39786855Age-related macular degeneration in patients with uveitis
Q38653249Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Q33892164Ascorbic acid concentrations in aqueous humor after systemic vitamin C supplementation in patients with cataract: pilot study
Q92524759Association of Dietary and Supplementary Calcium Intake With Age-Related Macular Degeneration: Age-Related Eye Disease Study Report 39
Q38877436Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores
Q45935732Brimonidine Can Prevent In Vitro Hydroquinone Damage on Retinal Pigment Epithelium Cells and Retinal Müller Cells.
Q35061844Carotenoids: potential allies of cardiovascular health?
Q28244515Choroid, Haller's, and Sattler's layer thickness in intermediate age-related macular degeneration with and without fellow neovascular eyes
Q53099086Choroidal structure in eyes with drusen and reticular pseudodrusen determined by binarisation of optical coherence tomographic images.
Q101051227Deep phenotype unsupervised machine learning revealed the significance of pachychoroid features in etiology and visual prognosis of age-related macular degeneration
Q38789140Dry Age-Related Macular Degeneration Pharmacology
Q49223224Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.
Q47104771Effect of neuroactive nutritional supplementation on body weight and composition in growing puppies
Q47355167Gaming to improve vision: 21st century self-monitoring for patients with age-related macular degeneration.
Q64235139Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice
Q36844624Hypoxia-induced metabolic stress in retinal pigment epithelial cells is sufficient to induce photoreceptor degeneration
Q33758205Immune responses in age-related macular degeneration and a possible long-term therapeutic strategy for prevention
Q36811078Impairments in Dark Adaptation Are Associated with Age-Related Macular Degeneration Severity and Reticular Pseudodrusen
Q30829406Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up
Q88985491Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes
Q37613100Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study
Q26782061Marine Carotenoids against Oxidative Stress: Effects on Human Health
Q39633569Monomeric C-reactive protein and inflammation in age-related macular degeneration
Q89687694Nutritional Supplements for Age-Related Macular Degeneration
Q60922653OCT Angiography and Cone Photoreceptor Imaging in Geographic Atrophy
Q93196288Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum
Q92516024Progression of subclinical choroidal neovascularization in age-related macular degeneration
Q34274040Projected changes in age-related macular degeneration and driving license holders in Finland
Q41532061Recent developments in age-related macular degeneration: a review.
Q89531841Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles
Q89454097Systemic Disease and Long-term Intraocular Pressure Mean, Peak, and Variability in Nonglaucomatous Eyes
Q41170382Taxifolin protects RPE cells against oxidative stress-induced apoptosis
Q37412560The Age-Related Macular Degeneration Complex: Linking Epidemiology and Histopathology Using the Minnesota Grading System (The Inaugural Frederick C. Blodi Lecture).
Q35744184The Effect of Zeaxanthin on the Visual Acuity of Zebrafish.
Q38692816The Pharmacological Effects of Lutein and Zeaxanthin on Visual Disorders and Cognition Diseases.
Q47418164The Relationship Between Plasma Concentrations of Lutein and Zeaxanthin with Self-Reported and Actual Prevalence of AMD in an Irish Population-Based Sample
Q49350422The fate of eyes with wet AMD beyond four years of anti-VEGF therapy.
Q39024579The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target
Q64076633Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules
Q52563441Treatment of Macular Degeneration with Sildenafil: Results of a Two-Year Trial.
Q54986895Visual acuity and contrast sensitivity are two important factors affecting vision-related quality of life in advanced age-related macular degeneration.
Q53018746[Atrophy of the macula in the context of its wet, age-related degeneration : An inescapable consequence of anti-VEGF therapy?]

Search more.